Fig. 3

USP35 expression in KIRC and its correlation with clinical variables and mutations. A Comparison of USP35 expression between tumor and normal tissues in KIRC based on GSE167573 and TCGA datasets. B Median expression of USP35 across different KIRC stages. C USP35 expression levels across KIRC stages I to IV. D Distribution of USP35 expression across molecular subtypes of KIRC based on TCGA data. E Clinical variables associated with high and low USP35 expression, including factors like grade, TNM stage, and hemoglobin levels. F Mutation profiles of KIRC patients with high and low USP35 expression, showing the frequency and type of mutations in key cancer-related genes such as VHL, PBRM1, and TTN